Cutaneous T-Cell Lymphoma (CTCL) Completed Phase 1 / 2 Trials for Vincristine (DB00541)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01198665RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasTreatment